The US congress has passed
new legislation defining who
has oversight for regulation of
compounding pharmacies, and
this week President Barack Obama
signed it into law.
The new Drug Quality and
Security Act creates an optional
FDA certification for large-scale
compounders described as
“outsourcing facilities,” as well as
establishing a national track and
trace system for compounded items.
This follows a fungal meningitis
outbreak caused by impure drugs.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Nov 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Nov 13
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.